Stephen J Freedland (Stephen Freedland)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 83

Top Topics

Positron Emission Tomography

Radical Prostatectomy

Prostate Cancer

Top Venues

Prostate cancer and prostatic diseases

BJU international

This page only lists publications with an associated author ORCID identifier.

Publications

Sriram Deivasigamani, Eric S Adams, Shannon Stock, Srinath Kotamarti, Denis Séguier, Tarek Taha, Lauren E Howard, Alireza Aminsharifi, Ghalib Jibara, Christopher L Amling, William J Aronson, Matthew R Cooperberg, Christopher J Kane, Martha K Terris, Zachary Klaassen, Lourdes Guerrios-Rivera, Stephen J Freedland, Thomas J Polascik
Select black men are potential candidates for prostate hemi-ablation based on radical prostatectomy histopathology for intermediate-risk prostate cancer-a multicenter SEARCH cohort study. Prostate cancer and prostatic diseases (2024)
Aum J Solanki, Mitchell Kamrava, Edwin M Posadas, Stephen J Freedland, Leslie Ballas, Howard M Sandler, C Noel Bairey Merz, Katelyn M Atkins, Andriana P Nikolova
A practical guide for assessing and managing cardiovascular risk during androgen-deprivation therapy in patients with prostate cancer. Cancer 130 (11) (2024)
Kelly K Bree, Jessica L Janes, Patrick J Hensley, Aditya Srinivasan, Amanda M De Hoedt, Sanjay Das, Stephen J Freedland, Stephen B Williams
Racial disparities in stage at bladder cancer diagnosis in the US Veterans Affairs healthcare system. BJU international 134 (3) (2024)
Mahdi Mottaghi, Lin Gu, Sriram Deivasigamani, Eric S Adams, Joshua Parrish, Christopher L Amling, William J Aronson, Christopher J Kane, Martha K Terris, Lourdes Guerrios-Rivera, Matthew R Cooperberg, Zachary Klaassen, Stephen J Freedland, Thomas J Polascik
Addressing racial disparities in prostate cancer pathology prediction models: external validation and comparison of four models of pathological outcome prediction before radical prostatectomy in the multiethnic SEARCH cohort. Prostate cancer and prostatic diseases (2024)
Kelly K Bree, Jessica L Janes, Patrick J Hensley, Aditya Srinivasan, Amanda M De Hoedt, Sanjay Das, Stephen J Freedland, Stephen B Williams
Racial disparities in stage at bladder cancer diagnosis in the US Veterans Affairs healthcare system. BJU international (2024)
Lourdes Guerrios-Rivera, Jessica L Janes, Amanda M De Hoedt, Zachary Klaassen, Martha K Terris, Matthew R Cooperberg, Christopher L Amling, Christopher J Kane, William J Aronson, Jay H Fowke, Stephen J Freedland
Do Hispanic Puerto Rican men have worse outcomes after radical prostatectomy? Results from SEARCH. Cancer medicine 13 (4) (2024)
Sriram Deivasigamani, Eric S Adams, Shannon Stock, Srinath Kotamarti, Denis Séguier, Tarek Taha, Lauren E Howard, Alireza Aminsharifi, Ghalib Jibara, Christopher L Amling, William J Aronson, Matthew R Cooperberg, Christopher J Kane, Martha K Terris, Zachary Klaassen, Lourdes Guerrios-Rivera, Stephen J Freedland, Thomas J Polascik
Select black men are potential candidates for prostate hemi-ablation based on radical prostatectomy histopathology for intermediate-risk prostate cancer-a multicenter SEARCH cohort study. Prostate cancer and prostatic diseases (2024)
Jeremiah R Dallmer, Brennan Spiegel, Stephen J Freedland, Rola Saouaf, Paige Kuhlmann, Timothy John Daskivich
Potential miscommunication of risk in American College of Radiology Prostate Imaging and Data System (PIRADS) scores. Prostate cancer and prostatic diseases (2024)
Margaret Meagher, Kylie Morgan, Leah Deshler, Paul Riviere, Isabella Dolendo, Brent Rose, Christina Jamieson, Sheldon Morris, Farnoosh Nik-Ahd, Stephen J Freedland, Jennifer Anger, Amirali Salmasi
Prostate cancer in transgender women: A propensity score-matched analysis of disease severity and survival. Cancer (2024)
Jun Gong, Jessica L Janes, Claire Trustram Eve, Shannon Stock, Justin Waller, Amanda M De Hoedt, Jeri Kim, Sameer R Ghate, Irene M Shui, Stephen J Freedland
Epidemiology, treatment patterns, and clinical outcomes in de novo oligometastatic hormone-sensitive prostate cancer. Cancer (2024)
Nadine A Friedrich, Lin Gu, Justin Waller, Amanda M De Hoedt, Zachary Klaassen, Stephen J Freedland
Real-world evidence of 18 F-fluciclovine Positron emission tomography/computed tomography performance for recurrent prostate cancer in the Veterans Affairs Health System. The Prostate (2024)
Kelly K Bree, Jessica L Janes, Patrick J Hensley, Aditya Srinivasan, Amanda M De Hoedt, Sanjay Das, Stephen J Freedland, Stephen B Williams
Racial disparities in stage at bladder cancer diagnosis in the US Veterans Affairs healthcare system. BJU international 134 (3) (2024)
Stephen J Freedland, Wei Gao, Angela Lax, Hongbo Yang, Krishnan Ramaswamy, David Russell, Agnes Hong, Jasmina I Ivanova
Real-world outcomes following biochemical recurrence after definitive therapy with a short prostate-specific antigen doubling time: potential role of early secondary treatment. Prostate cancer and prostatic diseases (2024)
Judd W Moul, Neal D Shore, Kenneth J Pienta, Johannes Czernin, Martin T King, Stephen J Freedland
Correction: Application of next-generation imaging in biochemically recurrent prostate cancer. Prostate cancer and prostatic diseases (2024)
Daniel J George, Archana M Agarwal, Krishnan Ramaswamy, Zachary Klaassen, Rhonda L Bitting, David Russell, Rickard Sandin, Birol Emir, Hongbo Yang, Wei Song, Yilu Lin, Agnes Hong, Wei Gao, Stephen J Freedland
Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer. Prostate cancer and prostatic diseases (2024)
Aum J Solanki, Mitchell Kamrava, Edwin M Posadas, Stephen J Freedland, Leslie Ballas, Howard M Sandler, C Noel Bairey Merz, Katelyn M Atkins, Andriana P Nikolova
A practical guide for assessing and managing cardiovascular risk during androgen-deprivation therapy in patients with prostate cancer. Cancer 130 (11) (2024)
Alanna Burwell, Stephen J Freedland, Jun Gong
Reducing Racial Inequalities in Prostate Cancer Treatment: Healthcare Access Barriers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (7) (2024)
Ilona Csizmadi, Stephen J Freedland
Adherence to the World Cancer Research Fund lifestyle recommendations and incidence of prostate cancer in UK Biobank. International journal of epidemiology 53 (1) (2024)
Aum J Solanki, Mitchell Kamrava, Edwin M Posadas, Stephen J Freedland, Leslie Ballas, Howard M Sandler, C Noel Bairey Merz, Katelyn M Atkins, Andriana P Nikolova
A practical guide for assessing and managing cardiovascular risk during androgen-deprivation therapy in patients with prostate cancer. Cancer (2024)
Daniel J George, Krishnan Ramaswamy, Hongbo Yang, Qing Liu, Adina Zhang, Alexandra Greatsinger, Jasmina I Ivanova, Betty Thompson, Birol Emir, Agnes Hong, Stephen J Freedland
Real-world overall survival with abiraterone acetate versus enzalutamide in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer. Prostate cancer and prostatic diseases (2024)
Nadine A Friedrich, Lin Gu, Justin Waller, Amanda M De Hoedt, Zachary Klaassen, Stephen J Freedland
Real-world evidence of 18 F-fluciclovine Positron emission tomography/computed tomography performance for recurrent prostate cancer in the Veterans Affairs Health System. The Prostate 84 (14) (2024)
Timothy John Daskivich, Aurash Naser-Tavakolian, Rebecca Gale, Michael Luu, Nadine A Friedrich, Abhi Venkataramana, Dmitry Khodyakov, Edwin Posadas, Howard M Sandler, Brennan Spiegel, Stephen J Freedland
Variation in communication of side effects in prostate cancer treatment consultations. Prostate cancer and prostatic diseases (2024)
Timothy John Daskivich, Aurash Naser-Tavakolian, Rebecca Gale, Michael Luu, Nadine A Friedrich, Abhi Venkataramana, Dmitry Khodyakov, Edwin Posadas, Howard M Sandler, Brennan Spiegel, Stephen J Freedland
Variation in communication of side effects in prostate cancer treatment consultations. Prostate cancer and prostatic diseases (2024)
Gloria Cecilia Galván, Everardo Macias, Sergio Sanders, Adela Ramirez-Torres, Shannon Stock, Sungyong You, Céline E Riera, Patrick Tamukong, Stephanie A Smith-Warner, Jeanine M Genkinger, Daniel J Luthringer, Michael R Freeman, Stephen J Freedland
The effects of glycemic index on prostate cancer progression in a xenograft mouse model. Prostate cancer and prostatic diseases (2023)
Gloria Cecilia Galván, Stephen J Freedland
Avocados: A Recipe for Good Guacamole or Lower Cancer Risk? Cancer prevention research (Philadelphia, Pa.) 16 (4) (2023)
Stephen J Freedland, Imtiaz A Samjoo, Emily Rosta, Austin Lansing, Evelyn Worthington, Alexander Niyazov, Jonathan L Nazari, Bhakti Arondekar
The impact of race on survival in metastatic prostate cancer: a systematic literature review. Prostate cancer and prostatic diseases (2023)
Sanjay Das, Stephen J Freedland
Statins and Cancer Prevention-Association Does Not Mean Causation. Cancer prevention research (Philadelphia, Pa.) 16 (1) (2023)
Gillian Gresham, Carolina Raines, Arash Asher, Stephen J Freedland, Celina H Shirazipour, Alix G Sleight
Can high-intensity interval training impact tumor suppression and inflammatory response in prostate cancer survivors? Prostate cancer and prostatic diseases (2023)
Gloria Cecilia Galván, James Percy Daniels, Nadine A Friedrich, Sanjay Das, Stephen J Freedland
A healthy diet, a healthy prostate? A brief commentary on the latest research on diet and prostate cancer. Prostate cancer and prostatic diseases (2023)
Ivy T Liu, Lin Gu, Amanda M De Hoedt, Matthew R Cooperberg, Christopher L Amling, Christopher J Kane, Zachary Klaassen, Martha K Terris, Lourdes Guerrios-Rivera, Adriana C Vidal, William J Aronson, Stephen J Freedland, Ilona Csizmadi
Are associations between obesity and prostate cancer outcomes following radical prostatectomy the same in smokers and non-smokers? Results from the SEARCH Cohort. Cancer causes & control : CCC (2023)
Neal D Shore, Judd W Moul, Kenneth J Pienta, Johannes Czernin, Martin T King, Stephen J Freedland
Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification. Prostate cancer and prostatic diseases (2023)
Andrei Sergeyev, Lin Gu, Amanda M De Hoedt, Christopher L Amling, William J Aronson, Matthew R Cooperberg, Christopher J Kane, Zachary Klaassen, Martha K Terris, Lourdes Guerrios-Rivera, Stephen J Freedland, Ilona Csizmadi
Diabetes and prostate cancer outcomes in men with nonmetastatic castrate-resistant prostate cancer: Results from the SEARCH Cohort. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
James Percy Daniels, Stephen J Freedland, Gillian Gresham
The growing implications of obesity for prostate cancer risk and mortality: where do we go from here? Journal of the National Cancer Institute (2023)
John M Masterson, Michael Luu, Aurash Naser-Tavakolian, Stephen J Freedland, Howard M Sandler, Zachary S Zumsteg, Timothy John Daskivich
Concurrent prognostic utility of lymph node count and lymph node density for men with pathological node-positive prostate cancer. Prostate cancer and prostatic diseases (2023)
Stephen J Freedland, Matthew R Davis, Andrew J Epstein, Bhakti Arondekar, Jasmina I Ivanova
Healthcare Costs in Men with Metastatic Castration-Resistant Prostate Cancer: An Analysis of US Medicare Fee-For-Service Claims. Advances in therapy (2023)
Jordan J Kramer, Lin Gu, Daniel Moreira, Gerald Andriole, Stephen J Freedland, Ilona Csizmadi
Smoking and lower urinary tract symptoms in Reduction by Dutasteride of Prostate Cancer Events Trial. The Prostate (2023)
Victor Pereira, Taofik Oyekunle, Jessica Janes, Christopher J Amling, William J Aronson, Matthew R Cooperberg, Christopher J Kane, Martha K Terris, Zachary Klaassen, Stephen J Freedland, Adriana C Vidal, Ilona Csizmadi
Time from biopsy to radical prostatectomy by race in an equal-access healthcare system: Results from the SEARCH cohort. The Prostate (2023)
Sanjay Das, Nadine A Friedrich, James Percy Daniels, Gloria Cecilia Galván, Jun Gong, Edwin M Posadas, William J Aronson, Stephen J Freedland
Relative search popularity of five advanced prostate cancer medications using Google Trends. Prostate cancer and prostatic diseases (2023)
Sanjay Das, Stephen J Freedland
Statins and Cancer Prevention-Association Does Not Mean Causation. Cancer prevention research (Philadelphia, Pa.) 16 (1) (2023)
James Percy Daniels, Devin N Patel, Gloria Cecilia Galván, Nadine A Friedrich, Sanjay Das, Arash Akhavein, Timothy John Daskivich, David Josephson, Premal Desai, Cosimo De Nunzio, Stephen J Freedland
Investigating trends in interest for benign prostatic hyperplasia surgery options using Google Trends. Prostate cancer and prostatic diseases (2023)
Jun Gong, Daniel M Kim, Amanda M De Hoedt, Neil A Bhowmick, Robert Figlin, Hyung Lae Kim, Howard M Sandler, Dan Theodorescu, Edwin M Posadas, Stephen J Freedland
Disparities With Systemic Therapies for Black Men Having Advanced Prostate Cancer: Where Do We Stand? Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Farnoosh Nik-Ahd, Jennifer T Anger, Matthew R Cooperberg, Stephen J Freedland
Prostate cancer is not just a man's concern - the use of PSA screening in transgender women. Nature reviews. Urology (2023)
Gloria Cecilia Galván, Sanjay Das, James Percy Daniels, Nadine A Friedrich, Stephen J Freedland
Working hard or hardly working? A brief commentary of latest research on exercise and prostate cancer. Prostate cancer and prostatic diseases (2023)
Jun Gong, Daniel M Kim, Michael R Freeman, Hyung Kim, Leigh Ellis, Bethany Smith, Dan Theodorescu, Edwin Posadas, Robert Figlin, Neil Bhowmick, Stephen J Freedland
Genetic and biological drivers of prostate cancer disparities in Black men. Nature reviews. Urology (2023)
Sanjay Das, Stephen J Freedland
Statins and Cancer Prevention-Association Does Not Mean Causation. Cancer prevention research (Philadelphia, Pa.) 16 (1) (2023)
Paige K Kuhlmann, Taofik Oyekunle, Zachary Klaassen, Christopher L Amling, William J Aronson, Matthew R Cooperberg, Christopher J Kane, Martha K Terris, Stephen J Freedland
A modeling study to estimate prostate cancer-specific mortality on active surveillance for men with favorable intermediate-risk prostate cancer: Results from the SEARCH cohort. Cancer medicine (2023)
Victor Pereira, Taofik Oyekunle, Jessica Janes, Christopher J Amling, William J Aronson, Matthew R Cooperberg, Christopher J Kane, Martha K Terris, Zachary Klaassen, Stephen J Freedland, Adriana C Vidal, Ilona Csizmadi
Time from biopsy to radical prostatectomy by race in an equal-access healthcare system: Results from the SEARCH cohort. The Prostate (2023)
Judd W Moul, Neal D Shore, Kenneth J Pienta, Johannes Czernin, Martin T King, Stephen J Freedland
Application of next-generation imaging in biochemically recurrent prostate cancer. Prostate cancer and prostatic diseases (2023)
Stephen J Freedland, Matthew Davis, Andrew J Epstein, Bhakti Arondekar, Jasmina I Ivanova
Real-world treatment patterns and overall survival among men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the US Medicare population. Prostate cancer and prostatic diseases (2023)
James Percy Daniels, James Mirocha, Michie A Adjei, Daniel Moreira, Stephen J Freedland
Serum Testosterone and Dihydrotestosterone and Incidence and Progression of Lower Urinary Tract Symptoms: Results From the REDUCE Study. The Journal of urology (2023)
Victor Pereira, Taofik Oyekunle, Jessica Janes, Christopher J Amling, William J Aronson, Matthew R Cooperberg, Christopher J Kane, Martha K Terris, Zachary Klaassen, Stephen J Freedland, Adriana C Vidal, Ilona Csizmadi
Time from biopsy to radical prostatectomy by race in an equal-access healthcare system: Results from the SEARCH cohort. The Prostate (2023)
Stephen J Freedland, Sandhya Nair, Xiwu Lin, Lawrence Karsh, Christopher Pieczonka, Ravi Potluri, Sabine D Brookman-May, Suneel D Mundle, Sarah Fleming, Neeraj Agarwal
A US real-world study of treatment patterns and outcomes in localized or locally advanced prostate cancer patients. World journal of urology (2023)
Mahmoud Mima, Jason B Huang, Gerald L Andriole, Stephen J Freedland, Samuel J Ohlander, Daniel M Moreira
The impact of smoking on sexual function. BJU international 130 (2) (2022)
Hann-Hsiang Chao, Payal D Soni, Bassam Dahman, Spiro C Stilianoudakis, Hampton Ford, Raj Singh, Stephen J Freedland, Drew Moghanaki, Neha Vapiwala, Michael G Chang
Outcomes following radical prostatectomy or external beam radiation for veterans with Gleason 9 and 10 prostate cancer. Cancer medicine 11 (15) (2022)
Lauren N Tholemeier, Catherine Bresee, Amanda M De Hoedt, Kamil E Barbour, Jayoung Kim, Stephen J Freedland, Jennifer T Anger
Do medication prescription patterns follow guidelines in a cohort of women with interstitial cystitis/bladder pain syndrome? Neurourology and urodynamics 41 (5) (2022)
Ruixin Yang, Di Zhu, Lauren E Howard, Amanda M De Hoedt, Florian R Schroeck, Zachary Klaassen, Stephen J Freedland, Stephen B Williams
Context-Based Identification of Muscle Invasion Status in Patients With Bladder Cancer Using Natural Language Processing. JCO clinical cancer informatics 6 (2022)
Stephen J Freedland, Nadine Adriana Friedrich
Nature versus nurture contribution to prostate cancer risk. Nature reviews. Urology 19 (11) (2022)
Ruixin Yang, Di Zhu, Lauren E Howard, Amanda M De Hoedt, Stephen B Williams, Stephen J Freedland, Zachary Klaassen
Identification of Patients With Metastatic Prostate Cancer With Natural Language Processing and Machine Learning. JCO clinical cancer informatics 6 (2022)
Adela Ramirez-Torres, Allison L Reagan, Lauren E Howard, Emily K Wiggins, Adriana C Vidal, Junxiang Wan, Brendan Miller, Stephen J Freedland, Pinchas Cohen
Racial differences in circulating mitochondria-derived peptides may contribute to prostate cancer health disparities. The Prostate 82 (13) (2022)
Kyle A Dymanus, Lauren E Howard, Taofik Oyekunle, Amanda M De Hoedt, Artak Labadzhyan, Thomas Polascik, Stephen J Freedland, Zachary Klaassen
Are higher pre-diagnosis follicle stimulating hormone levels associated with long-term prostate cancer risk? The Prostate 82 (16) (2022)
Stephen J Freedland, Agnes Hong, Nader El-Chaar, Sharanya Murty, Krishnan Ramaswamy, Anna D Coutinho, David Nimke, Alicia K Morgans
Prostate-specific antigen response and clinical progression-free survival in Black and White men with chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide in a real-world setting. Prostate cancer and prostatic diseases (2022)
Hanson Hanqing Zhao, Lauren E Howard, Amanda M De Hoedt, Martha K Terris, Christopher L Amling, Christopher J Kane, Matthew R Cooperberg, William J Aronson, Zachary Klaassen, Thomas J Polascik, Adriana C Vidal, Stephen J Freedland
Safety of concomitant therapy with radium-223 and abiraterone or enzalutamide in a real-world population. The Prostate 81 (7) (2021)
Jen-Tsan Ashley Chi, Pao-Hwa Lin, Vladimir Tolstikov, Taofik Oyekunle, Gloria C G Alvarado, Adela Ramirez-Torres, Emily Y Chen, Valerie Bussberg, Bo Chi, Bennett Greenwood, Rangaprasad Sarangarajan, Niven R Narain, Michael A Kiebish, Stephen J Freedland
The influence of low-carbohydrate diets on the metabolic response to androgen-deprivation therapy in prostate cancer. The Prostate 81 (10) (2021)
Corinne Lawler, Lin Gu, Lauren E Howard, Brandee Branche, Emily Wiggins, Aditya Srinivasan, Meagan L Foster, Zachary Klaassen, Amanda M De Hoedt, Jeffrey R Gingrich, Dan Theodorescu, Stephen J Freedland, Stephen B Williams
The impact of the social construct of race on outcomes among bacille Calmette-Guérin-treated patients with high-risk non-muscle-invasive bladder cancer in an equal-access setting. Cancer 127 (21) (2021)
Alexis LeVee, Ching Ying Lin, Edwin Posadas, Robert Figlin, Neil A Bhowmick, Dolores Di Vizio, Leigh Ellis, Charlos J Rosser, Michael R Freeman, Dan Theodorescu, Stephen J Freedland, Jun Gong
Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection. OncoTargets and therapy 14 (2021)
Alexis R Freedland, Roberto L Muller, Catherine Hoyo, Elizabeth L Turner, Patricia G Moorman, Eliney Ferreira Faria, Gustavo F Carvalhal, Rodolfo Borges Dos Reis, Edmundo C Mauad, Andre L Carvalho, Stephen J Freedland
Implications of Regionalizing Care in the Developing World: Impact of Distance to Referral Center on Compliance to Biopsy Recommendations in a Brazilian Prostate Cancer Screening Cohort. Prostate cancer 2021 (2021)
Sonia Kelkar, Taofik Oyekunle, Adva Eisenberg, Lauren Howard, William J Aronson, Christopher J Kane, Christopher L Amling, Matthew R Cooperberg, Zachary Klaassen, Martha K Terris, Stephen J Freedland, Ilona Csizmadi
Diabetes and Prostate Cancer Outcomes in Obese and Nonobese Men After Radical Prostatectomy. JNCI cancer spectrum 5 (3) (2021)
Stephen J Freedland, Rickard Sandin, Janvi Sah, Birol Emir, Qiao Mu, Anna Ratiu, Agnes Hong, Lucile Serfass, Scott T Tagawa
Treatment patterns and survival in metastatic castration-sensitive prostate cancer in the US Veterans Health Administration. Cancer medicine 10 (23) (2021)
Stephen J Freedland, Ugo De Giorgi, Martin Gleave, Brad Rosbrook, Qi Shen, Jennifer Sugg, Gabriel P Haas, Neal D Shore
A phase 3 randomised study of enzalutamide plus leuprolide and enzalutamide monotherapy in high-risk non-metastatic hormone-sensitive prostate cancer with rising PSA after local therapy: EMBARK study design. BMJ open 11 (8) (2021)
Sean Kennedy Barlow, Taofik Oyekunle, Jessica L Janes, Amanda M De Hoedt, William J Aronson, Christopher J Kane, Christopher L Amling, Matthew R Cooperberg, Zachary W Klaassen, Martha K Terris, Stephen J Freedland, Ilona Csizmadi
Prostate weight and prostate cancer outcomes after radical prostatectomy: Results from the SEARCH cohort study. The Prostate 82 (3) (2021)
Claire M Di Bella, Lauren E Howard, Taofik Oyekunle, Amanda M De Hoedt, Joseph K Salama, Haijun Song, Stephen J Freedland, Emma H Allott
Abdominal and pelvic adipose tissue distribution and risk of prostate cancer recurrence after radiation therapy. The Prostate 80 (14) (2020)
Adriana C Vidal, Taofik Oyekunle, Lauren E Howard, Amanda M De Hoedt, Christopher J Kane, Martha K Terris, Matthew R Cooperberg, Christopher L Amling, Zachary Klaassen, Stephen J Freedland, William J Aronson
Obesity, race, and long-term prostate cancer outcomes. Cancer 126 (16) (2020)
Emily K Wiggins, Taofik Oyekunle, Lauren E Howard, Sarah C Markt, Lorelei A Mucci, Donald L Bliwise, Daniel M Moreira, Gerald L Andriole, Martin L Hopp, Stephen J Freedland, Emma H Allott
Sleep quality and prostate cancer aggressiveness: Results from the REDUCE trial. The Prostate 80 (15) (2020)
Devin N Patel, Lauren E Howard, Amanda M De Hoedt, Christopher L Amling, William J Aronson, Matthew R Cooperberg, Christopher J Kane, Zachary W Klaassen, Martha K Terris, Stephen J Freedland
Race does not predict skeletal-related events and all-cause mortality in men with castration-resistant prostate cancer. Cancer 126 (14) (2020)
Ingrid Lorese Tablazon, Lauren E Howard, Amanda M De Hoedt, William J Aronson, Christopher J Kane, Christopher L Amling, Matthew R Cooperberg, Martha K Terris, Stephen J Freedland, Stephen B Williams
Predictors of skeletal-related events and mortality in men with metastatic, castration-resistant prostate cancer: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Cancer 125 (22) (2019)
Jun Wang, Wenhao Xu, Abudurexiti Mierxiati, Yongqiang Huang, Yu Wei, Guowen Lin, Bo Dai, Stephen J Freedland, Xiaojian Qin, Yao Zhu, Ding-Wei Ye
Low-serum prostate-specific antigen level predicts poor outcomes in patients with primary neuroendocrine prostate cancer. The Prostate 79 (13) (2019)
Celina H Shirazipour, Stephen J Freedland
Obesity, visceral adiposity, and prostate cancer: What is the role of lifestyle interventions? Cancer 125 (16) (2019)
Farnoosh Nik-Ahd, Lauren E Howard, Adva T Eisenberg, William J Aronson, Martha K Terris, Matthew R Cooperberg, Christopher L Amling, Christopher J Kane, Stephen J Freedland
Poorly controlled diabetes increases the risk of metastases and castration-resistant prostate cancer in men undergoing radical prostatectomy: Results from the SEARCH database. Cancer 125 (16) (2019)
Emma H Allott, Ilona Csizmadi, Lauren E Howard, Roberto L Muller, Daniel M Moreira, Gerald L Andriole, Claus G Roehrborn, Stephen J Freedland
Statin use and longitudinal changes in prostate volume; results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial. BJU international 125 (2) (2019)
Thomas J Polascik, Ariel A Schulman, Lauren E Howard, Kae Jack Tay, Christopher L Amling, William J Aronson, Matthew R Cooperberg, Christopher J Kane, Martha K Terris, Stephen J Freedland, Thomas J Polascik
Influence of African American race on the association between preoperative biopsy grade group and adverse histopathologic features of radical prostatectomy. Cancer 125 (17) (2019)
Christine Herforth, Sean P Stroup, Zinan Chen, Lauren E Howard, Stephen J Freedland, Daniel M Moreira, Martha K Terris, William J Aronson, Matthew R Cooperberg, Christopher L Amling, Christopher J Kane
Radical prostatectomy and the effect of close surgical margins: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. BJU international 122 (4) (2018)
Andrew G Kuang, J Curtis Nickel, Gerald L Andriole, Ramiro Castro-Santamaria, Stephen J Freedland, Daniel M Moreira
Both acute and chronic inflammation are associated with less perineural invasion in men with prostate cancer on repeat biopsy. BJU international 123 (1) (2018)
Stephen J Freedland, Brandee L Branche, Lauren E Howard, Robert J Hamilton, William J Aronson, Martha K Terris, Matthew R Cooperberg, Christopher L Amling, Christopher J Kane, null null
Obesity, risk of biochemical recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database. BJU international 124 (1) (2018)